Closed |
SWOG-9320 |
AIDS-RELATED: ProMACE-CytaBOM w/trimethoprim sulfa, G-CSF, and antiretroviral therapy (followed by brain RT) |
5/1/1994 |
12/1/2000 |
100% |
|
Published
|
Closed |
SWOG-9426 |
Advanced Prostate |
3/15/1995 |
6/1/2001 |
100% |
|
Published
|
Closed |
S9704 |
NON-HODGKIN'S: CHOP x 8 vs. CHOP x 6 followed by TBI/VP-6/cylophosphamide or SWOG BCV with stem cell rescue |
9/15/1997 |
12/15/2007 |
100% |
|
Published
|
Closed |
S9717 |
CERVICAL |
8/15/1998 |
8/15/2000 |
100% |
|
Published
|
Closed |
S9720 |
ENDOMETRIAL |
2/15/1998 |
7/15/2000 |
100% |
|
Published
|
Closed |
S9810 |
Mesothelioma |
2/15/1999 |
8/15/2000 |
100% |
|
Published
|
Closed |
S9812 |
GU/Prostate |
6/15/1999 |
6/1/2001 |
100% |
|
Published
|
Closed |
S9832 |
Breast Recurrence |
7/15/1998 |
11/15/2002 |
100% |
|
Published
|
Closed |
S9912 |
OVARIAN |
10/1/2000 |
8/15/2005 |
100% |
|
Published
|
Closed |
S9916 |
Advanced Prostate |
10/15/1999 |
1/15/2003 |
100% |
|
Published
|
Closed |
S0014 |
NON-HODGKIN'S: CHOP with concurrent rituximab plus IFR |
4/1/2000 |
1/15/2002 |
100% |
|
Published
|
Closed |
SWOG-9151 |
Evaluation of Topotecan in Hepatoma, Phase II |
2/1/1992 |
6/15/1993 |
100% |
|
Published
|
Closed |
SWOG-226 |
Phase II Protocol for Porfiromycin Solid Tumors |
7/12/1967 |
|
100% |
|
|
Closed |
SWOG-8732 |
Evaluation of Amonafide in Endometrial Carcinoma |
3/1/1988 |
3/1/1991 |
100% |
|
Published
|
Closed |
SWOG-8802 |
Evaluation of Echinomycin in Renal Cell Carcinoma |
1/15/1989 |
7/15/1990 |
100% |
|
Published
|
Closed |
S9632 |
Enhancing Well-Being During Breast Cancer Recurrence |
6/1/1997 |
8/1/1998 |
100% |
|
Published
|
Closed |
SWOG-8720 |
Evaluation of Amonafide in Pancreatic Adenocarcinoma |
7/1/1988 |
7/15/1990 |
100% |
|
Published
|
Closed |
SWOG-9241 |
Evaluation of Topotecan in Colorectal Cancer, Phase II |
7/15/1993 |
11/15/1994 |
100% |
|
Published
|
Closed |
SWOG-7436 |
CMFVP vs Melphalan for operable breast cancer |
1/9/1975 |
7/18/1979 |
100% |
|
Published
|
Closed |
SWOG-8913 |
Evaluation of Merbarone in Malignant Melanoma, Phase II |
9/1/1991 |
6/15/1993 |
100% |
|
Published
|